Determinants of Limiting Life-Sustaining Treatment in Critically Ill COVID-19 Patients: A Multicenter Study in Korean ICUs |
I Re Heo1, Tae Hoon Kim1, Won Jai Jung2, Gil Myeong Seong3, Sun Jung Kwon4, Jae Young Moon5, Song-I Lee6, Do Sik Moon7, Tae-Ok Kim8, Chul Park9, Eun Young Choi10, Jung-Wan Yoo11, Sunghoon Park12, Ae Rin Baek13, Sung Yoon Lim14, Jung Soo Kim15, Jongmin Lee16, Chi Ryang Chung17, Sang-Min Lee18, Su Hwan Lee19, Moon Seong Baek20, Jin Won Huh21, Woo Hyun Cho22, Ho Cheol Kim1 |
1Department of Internal Medicine, Gyeongsang National University Changwon Hospital, Gyeongsang National University School of Medicine, Changwon, Korea 2Division of Pulmonary, Allergy, and Critical Care Medicine, Korea University Anam Hospital, Seoul, Korea 3Department of Internal Medicine, Jeju National University Hospital, Jeju National University School of Medicine, Jeju, Korea 4Division of Respiratory and Critical Care Medicine, Department of Internal Medicine, Konyang University Hospital, Daejeon, Korea 5Department of Internal Medicine, Chungnam National University College of Medicine, Chungnam National University Sejong Hospital, Sejong, Korea 6Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungnam National University College of Medicine, Chungnam National University Hospital, Daejeon, Korea 7Department of Pulmonology and Critical Care Medicine, Chosun University Hospital, Gwangju, Korea 8Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chonnam National University Hospital, Gwangju, Korea 9Division of Pulmonology and Critical Care Medicine, Wonkwang University Hospital, Iksan, Korea 10Division of Pulmonology and Allergy, Department of Internal Medicine, College of Medicine, Yeungnam University and Regional Center for Respiratory Diseases, Yeungnam University Medical Center, Daegu, Korea 11Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea 12Division of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea 13Division of Allergy and Pulmonary Medicine, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea 14Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, Seoul National University Bundang Hospital, Seongnam, Korea 15Division of Critical Care Medicine, Department of Hospital Medicine, Inha College of Medicine, Incheon, Korea 16Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea 17Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea 18Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea 19Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea 20Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Korea 21Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 22Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Internal Medicine, Transplant Research Center, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Korea |
Correspondence:
Ho Cheol Kim, Tel: +82-55-214-3730, Fax: +82-55-214-8618, Email: hockkim@gnu.ac.kr |
Received: 20 September 2024 • Revised: 5 January 2025 • Accepted: 31 March 2025 |
Abstract |
Background Understanding life-sustaining treatment (LST) decisions in critically ill COVID-19 patients remains limited. This study aimed to identify factors influencing LST decisions and compare clinical outcomes between patients with and without LST.
Methods This multicenter, retrospective cohort study analyzed data from 1,081 COVID-19 patients admitted to ICUs across Korea from January 1, 2020, to August 31, 2021. Patients were divided into LST and non-LST groups. Demographic, clinical, and outcome data were collected and compared.
Results Of 1,081 patients, 207 (19.2%) received LST. LST patients were older (median age: 76 vs. 67 years, p < 0.001) and had more comorbidities (85.5% vs. 70.4%, p < 0.001), particularly cardiovascular and chronic lung disease. They had higher BUN, lower albumin, and elevated D-dimer levels (all p < 0.05). ICU interventions, including mechanical ventilation (82.6% vs. 50.9%, p < 0.001) and ECMO (18.8% vs. 9.8%, p < 0.001), were more common. ICU and hospital mortality rates were significantly higher in LST patients (82.6% and 94.2%, respectively, p < 0.001). Logistic regression identified age (OR = 1.054 per year, p < 0.001), mechanical ventilation (OR = 2.789, p = 0.002), and ECMO use (OR = 3.580, p = 0.002) as independent predictors of LST.
Conclusion Age, comorbidities, and ICU interventions significantly influence LST decisions, highlighting the need for ethical and evidence-based critical care guidelines. |
Key Words:
COVID-19, Life-sustaining treatments, ICU, Mechanical ventilation, ECMO, Predictors, Retrospective cohort, Korea |
|